relapsed adult all
Showing 1 - 6 of 6
Relapsed Adult ALL, Relapsed Adult AML Trial in Changchun (Plerixafor)
Active, not recruiting
- Relapsed Adult ALL
- Relapsed Adult AML
-
Changchun, Jilin, ChinaFirst Hospital of Jilin University
Nov 19, 2023
CAR, Refractory Acute Lymphoblastic Leukemia, Relapsed Adult ALL Trial in Suzhou (Treatment)
Recruiting
- CAR
- +2 more
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Dec 27, 2022
Refractory B-Cell Non-Hodgkin Lymphoma, Refractory B-Cell Small Lymphocytic Lymphoma, Relapsed Adult ALL Trial in Houston
Recruiting
- Refractory B-Cell Non-Hodgkin Lymphoma
- +4 more
- CD19.CAR-aNKT cells
- +2 more
-
Houston, Texas
- +1 more
Aug 19, 2022
Relapsed Non Hodgkin Lymphoma, Relapsed Adult ALL, Relapsed Pediatric ALL Trial in Calgary, Edmonton (autologous CD19-directed
Recruiting
- Relapsed Non Hodgkin Lymphoma
- +2 more
- autologous CD19-directed chimeric antigen receptor (CAR) T-cells
-
Calgary, Alberta, Canada
- +5 more
Jul 18, 2022
Relapsed Adult ALL, B Cell Leukemia Trial in Chongqing (anti-CD19 allo-CAR-T cells)
Recruiting
- Relapsed Adult ALL
- B Cell Leukemia
- anti-CD19 allo-CAR-T cells
-
Chongqing, Chongqing, ChinaDepartment of Hematology, Xinqiao Hospital
Nov 12, 2020
Hematologic Cancer, Relapse Leukemia, Relapsed Adult ALL Trial in Montreal (GLIDE)
Unknown status
- Hematologic Cancer
- +8 more
- GLIDE
-
Montreal, Quebec, CanadaCIUSSS d l'Est-de-l'Île-de-Montréal
Dec 4, 2017